Cite
Zahn NM, Mikulsky BN, Roni MSR, et al. Nebulized MIDD0301 Reduces Airway Hyperresponsiveness in Moderate and Severe Murine Asthma Models. ACS Pharmacol Transl Sci. 2020;3(6):1381-1390doi: 10.1021/acsptsci.0c00180.
Zahn, N. M., Mikulsky, B. N., Roni, M. S. R., Yocum, G. T., Mian, M. Y., Knutson, D. E., Cook, J. M., Emala, C. W., Stafford, D. C., & Arnold, L. A. (2020). Nebulized MIDD0301 Reduces Airway Hyperresponsiveness in Moderate and Severe Murine Asthma Models. ACS pharmacology & translational science, 3(6), 1381-1390. https://doi.org/10.1021/acsptsci.0c00180
Zahn, Nicolas M, et al. "Nebulized MIDD0301 Reduces Airway Hyperresponsiveness in Moderate and Severe Murine Asthma Models." ACS pharmacology & translational science vol. 3,6 (2020): 1381-1390. doi: https://doi.org/10.1021/acsptsci.0c00180
Zahn NM, Mikulsky BN, Roni MSR, Yocum GT, Mian MY, Knutson DE, Cook JM, Emala CW, Stafford DC, Arnold LA. Nebulized MIDD0301 Reduces Airway Hyperresponsiveness in Moderate and Severe Murine Asthma Models. ACS Pharmacol Transl Sci. 2020 Dec 02;3(6):1381-1390. doi: 10.1021/acsptsci.0c00180. eCollection 2020 Dec 11. PMID: 33344908; PMCID: PMC7737320.
Copy
Download .nbib